Chris Abell
Computational Chemistry & Drug Discovery · 2002–2016
A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 2 researchers here, as inferred from the citation graph.
Subfields
- Computational Chemistry & Drug Discovery — 10 citations into it
Whom Chris Abell trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Chris Abell overall
Papers from Chris Abell's perspective
Ordered by how strongly the researchers Chris Abell trusts endorse each paper. Same corpus, a different order for every researcher.
- The Protein Data Bank.
- Functionality maps of binding sites: A multiple copy simultaneous search method
- Protein structure--based drug design.
- Drug discovery: a historical perspective. (Science)
- Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
- Drug-like properties and the causes of poor solubility and poor permeability. (Journal of pharmacological and toxicological methods)
- An inhibitor of Bcl-2 family proteins induces regression of solid tumours (Nature)
- The Pfam protein families database
- SCOP: a structural classification of proteins database for the investigation of sequences and structures.
- Crystallography & NMR system: A new software suite for macromolecular structure determination.
Their papers
- High-throughput crystallography for lead discovery in drug design (2002) — 503 citations
- Small molecules, big targets: drug discovery faces the protein–protein interaction challenge (2016) — 971 citations